title: Injection-Site Nodules Associated With the Use of Exenatide Extended-Release Reported to the U.S. Food and Drug Administration Adverse Event Reporting System.
authors.affiliation: U.S. Food and Drug Administration Office of Pharmacovigilance and Epidemiology and Office of New Drugs, Silver Spring, MD.
authors.forename: S Christopher
authors.initials: SC
authors.lastname: Jones
authors.affiliation: U.S. Food and Drug Administration Office of Pharmacovigilance and Epidemiology and Office of New Drugs, Silver Spring, MD.
authors.forename: Debra L
authors.initials: DL
authors.lastname: Ryan
authors.affiliation: U.S. Food and Drug Administration Office of Pharmacovigilance and Epidemiology and Office of New Drugs, Silver Spring, MD.
authors.forename: Valerie S W
authors.initials: VS
authors.lastname: Pratt
authors.affiliation: U.S. Food and Drug Administration Office of Pharmacovigilance and Epidemiology and Office of New Drugs, Silver Spring, MD.
authors.forename: Ali
authors.initials: A
authors.lastname: Niak
authors.affiliation: U.S. Food and Drug Administration Office of Pharmacovigilance and Epidemiology and Office of New Drugs, Silver Spring, MD.
authors.forename: Allen D
authors.initials: AD
authors.lastname: Brinker